Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus : American Journal of Therapeutics

Secondary Logo

Journal Logo

Therapeutic Advance

Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus

Wong, Elaine PharmD, MBA, BCPS, BC-ADM1; Cope, Rebecca PharmD, MPH, BCACP1; Dima, Lorena MD, PhD2,*; Nguyen, Timothy PharmD, MBA, BCPS, FASCP1

Author Information
American Journal of Therapeutics 30(1):p e26-e35, January/February 2023. | DOI: 10.1097/MJT.0000000000001588

Abstract

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid